![Early phase clinical trials extension to guidelines for the content of statistical analysis plans | The BMJ Early phase clinical trials extension to guidelines for the content of statistical analysis plans | The BMJ](https://www.bmj.com/content/bmj/376/bmj-2021-068177/F1.medium.jpg)
Early phase clinical trials extension to guidelines for the content of statistical analysis plans | The BMJ
![Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics - eBioMedicine Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d64ba247-3929-40e8-93dd-584e80b02e66/gr1.jpg)
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics - eBioMedicine
![Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/09/9-3-19-Persepectives-blog-What-is-Phase-1-2-3-image-for-9-3-19-final-.jpg)
Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals
![Predictive modeling of clinical trial terminations using feature engineering and embedding learning | Scientific Reports Predictive modeling of clinical trial terminations using feature engineering and embedding learning | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-82840-x/MediaObjects/41598_2021_82840_Fig1_HTML.png)
Predictive modeling of clinical trial terminations using feature engineering and embedding learning | Scientific Reports
![Agile research to complement agile development: a proposal for an mHealth research lifecycle | npj Digital Medicine Agile research to complement agile development: a proposal for an mHealth research lifecycle | npj Digital Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41746-018-0053-1/MediaObjects/41746_2018_53_Fig1_HTML.png)
Agile research to complement agile development: a proposal for an mHealth research lifecycle | npj Digital Medicine
![Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41231-019-0050-7/MediaObjects/41231_2019_50_Fig1_HTML.png)